Full text loading...
-
The PI3 Kinase Signaling Pathway in Prostate Cancer
- Source: Current Cancer Drug Targets, Volume 13, Issue 2, Feb 2013, p. 157 - 164
-
- 01 Feb 2013
Abstract
Despite recent advances in our understanding of the biological basis of prostate cancer, the management of the disease, especially in the castration-resistant phase, remains a significant challenge. Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is increasingly implicated in a number of malignancies, including prostate carcinogenesis. In this review, we detail the role of this pathway in the pathogenesis of prostate cancer and the therapeutic implications of targeting it.
© Bentham Science Publishers